Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Short term Debt (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Short term Debt for 10 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Short term Debt rose 1066.25% to $1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 million, a 1066.25% increase, with the full-year FY2025 number at $1.9 million, up 1066.25% from a year prior.
  • Short term Debt was $1.9 million for Q4 2025 at Orthopediatrics, up from $166000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.9 million in Q4 2025 to a low of $132000.0 in Q1 2021.
  • A 5-year average of $294400.0 and a median of $149000.0 in 2023 define the central range for Short term Debt.
  • Biggest YoY gain for Short term Debt was 1066.25% in 2025; the steepest drop was 73.4% in 2025.
  • Orthopediatrics' Short term Debt stood at $137000.0 in 2021, then increased by 5.11% to $144000.0 in 2022, then rose by 5.56% to $152000.0 in 2023, then grew by 5.26% to $160000.0 in 2024, then surged by 1066.25% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Short term Debt are $1.9 million (Q4 2025), $166000.0 (Q3 2025), and $164000.0 (Q2 2025).